USP13 and cancer: Moreover, incubation with USP13 inhibitor spautin-1 reduces survival of OVCA cell lines after replication stress inducing agents, implying that the development of selective USP13 inhibitors is feasible for treatment of these patients of conventional cancer chemotherapy (Kim et al., 2021).